Results 11 to 20 of about 68,836 (267)

Cardio-renal syndrome [version 1; referees: 3 approved] [PDF]

open access: goldF1000Research, 2016
Cardio-renal syndrome is a commonly encountered problem in clinical practice. Its pathogenesis is not fully understood. The purpose of this article is to highlight the interaction between the cardiovascular system and the renal system and how their ...
Joseph Gnanaraj, Jai Radhakrishnan
doaj   +6 more sources

The association of illness perception and related factors with treatment adherence among chronic hemodialysis patients with cardio-renal syndrome in Yemen [PDF]

open access: goldFrontiers in Cardiovascular Medicine
BackgroundPatients’ illness perceptions are cognitive representations or beliefs structured around their condition. These perceptions have been associated with several important outcomes, including functional recovery and treatment adherence.ObjectiveThe
Adel Omar Laradhi   +8 more
doaj   +4 more sources

Biomarkers of cardio-renal syndrome in uremic myocardiopathy animal model [PDF]

open access: greenBrazilian Journal of Nephrology, 2018
Introduction: Cardio-renal syndrome subtype 4 (CRS4) is a condition of primary chronic kidney disease that leads to reduction of cardiac function, ventricular hypertrophy, and risk of cardiovascular events.
Laura Mattana Dionísio   +10 more
doaj   +3 more sources

Novel Biomarkers for Cardio-renal Syndrome. [PDF]

open access: greenElectrolyte Blood Press, 2012
Cardio-renal syndrome (CRS) is a frequent and life-threatening syndrome. It is a disorder of the heart and kidneys in which acute or chronic dysfunction in one organ may induce acute or chronic dysfunction in the other organ. Acute kidney injury (AKI) is strongly associated with increased morbidity and mortality in patients with CRS. Early detection of
Lee SR, Jeong KH.
europepmc   +6 more sources

Exosomes: a potential key target in cardio-renal syndrome [PDF]

open access: yesFrontiers in Immunology, 2014
Exosomes have proven roles in regulating immune response, antigen presentation, RNA and protein transfer, and cell–cell (organ–organ) interaction/signaling.
Laura eGonzalez-Calero   +2 more
doaj   +5 more sources

Pharmacologic Management of the Cardio-renal Syndrome. [PDF]

open access: greenElectrolyte Blood Press, 2013
Cardio-renal syndromes are disorders of the heart and kidney wherein acute or long-term dysfunction in one organ may induce acute or long-term dysfunction of the other. Because of this complex organ interaction, management of cardiorenal syndrome must be tailored to the underlying pathophysiology.
Kim CS.
europepmc   +6 more sources

Potential Neuromodulation of the Cardio-Renal Syndrome. [PDF]

open access: yesJ Clin Med, 2023
The cardio-renal syndrome (CRS) type 2 is defined as a progressive loss of renal function following a primary insult to the myocardium that may be either acute or chronic but is accompanied by a decline in myocardial pump performance. The treatment of patients with CRS is difficult, and the disease often progresses to end-stage renal disease that is ...
Zucker IH, Xia Z, Wang HJ.
europepmc   +3 more sources

Pathophysiology of the cardio-renal syndromes types 1–5: An uptodate

open access: goldIndian Heart Journal, 2017
According to the recent definition proposed by the Consensus conference on Acute Dialysis Quality Initiative Group, the term cardio-renal syndrome (CRS) has been used to define different clinical conditions in which heart and kidney dysfunction overlap ...
L. Di Lullo   +7 more
doaj   +2 more sources

The Role of Omentin-1 in Cardio-renal Syndrome [PDF]

open access: diamondKirkuk Journal of Science, 2016
Acute heart disease patients often go on to develop worsening renal function, termed as a cardiorenal syndrome(CRS). Cardiorenal syndrome is defined as “disorders of the heart and kidneys where by acute or chronic dysfunction in one organ may induce ...
Nagham Q. Kazim, Nazar A. Naji
doaj   +3 more sources

Cardio-Renal Anemia Syndrome

open access: green, 2011
Heart failure (HF) is a systemic disease that also involves organs and tissues other than the heart and the vasculature. Between 25 and 50% of patients with HF are also affected by some degree of kidney disease. Anemia may be present in patients with HF, particularly if the kidney is also affected.
Stephan von Haehling, Stefan D. Anker
openalex   +4 more sources

Home - About - Disclaimer - Privacy